William Blair’s Louise Lane, ranked a top woman wealth advisor in America by Barron’s, discusses with the magazine how she stayed ahead in the competitive financial services industry and continues to build clients’ wealth.
Private Wealth Management
Louise Lane Featured in Barron's
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
-
Aardvark Therapeutics, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Aardvark Therapeutics, Inc. (AARD $13.98). Aardvark is advancing ARD-101, an oral therapy that targets bitter taste receptors (TAS2Rs) in the gastrointestinal tract, and ARD-201, a combination of ARD-101 and a DPP-4 inhibitor, for treating Prader-Willi syndrome (PWS) and obesity, respectively.
-